Key Highlights
- Teradyne reported second-quarter 2026 record Revenue of around $1.33 billion, more than doubling year over year.
- Its semiconductor-test Business surged on Demand for AI computing chips and advanced memory testing.
- The company also signaled that breakneck sequential growth was leveling off, guiding to a slight decline the following quarter.
- Teradyne's robotics business, making collaborative robots for factories, has been slower to grow than its core testing operations.
Before any chip reaches a customer, it must be tested to make sure it works, and Teradyne (NASDAQ:TER) makes the machines that do the testing. As artificial-intelligence chips and the memory that supports them proliferate, demand for that testing has surged, putting Teradyne at the centre of a Nasdaq 100 technology story.
What Teradyne Does
Teradyne makes automated test equipment, the machines that check semiconductors for defects and confirm they perform as intended before they are shipped. It sits in the technology sector. It also has a robotics business, making collaborative robots that work alongside people in factories. Its core semiconductor-test business serves chipmakers across the industry, and as chips have become more complex and more valuable, ensuring they work correctly has become both more difficult and more important, driving demand for Teradyne's equipment.
AI Drives a Testing Boom
Teradyne has enjoyed a remarkable surge. In the second quarter of 2026 it reported record revenue of around 1.33 billion US dollars, more than doubling year on year, with its semiconductor-test business surging on the back of demand for AI computing chips and for advanced memory, including strength in DRAM and a resurgence in flash-memory testing. This reflects a simple reality: more chips, and more complex chips, mean more testing. However, the company also signalled that the breakneck sequential growth was levelling off, guiding to a slight decline in the following quarter, a reminder that even strong demand moves in waves and that testing equipment is a cyclical business tied to chip production.
Why it Matters for the Nasdaq 100
Teradyne offers the index exposure to the AI build-out through the essential but overlooked step of chip testing. Its results reveal how many advanced chips are being produced, an indicator of activity across the semiconductor industry. As a member of the benchmark with exposure to both chip testing and robotics, it provides a way to participate in the chip boom, while its cyclical nature makes its guidance a useful signal of where the semiconductor cycle may be heading.
The Cyclical Nature of Testing
Teradyne's exposure to the semiconductor cycle deserves particular attention, because it shapes how to read the company. Demand for test equipment rises and falls with chip production: when chipmakers ramp up output, they need more testers, and when they slow, orders drop. The AI boom has driven a powerful surge, but the recent signal that sequential growth is levelling off shows how quickly the pace can change. This cyclicality means Teradyne's results can be volatile, with periods of rapid growth followed by pauses as customers digest the equipment they have bought. For investors, this makes the direction of guidance, and commentary on where in the cycle the industry sits, particularly important, since the shares tend to move on expectations of future demand rather than on current results alone.
The Risks to Weigh
The test-equipment business is cyclical, so demand can drop sharply when chip production slows. Teradyne depends on a relatively small number of large customers, concentrating risk. Exposure to China and any trade tensions are concerns. The robotics business, while promising, has been slower to grow. Competition is significant, and the shares can be volatile, reflecting shifts in sentiment about the chip cycle and expectations that leave little room for disappointment.
Testing the Pulse of the Chip Cycle
Readers should track semiconductor-test revenue and, especially, Teradyne's guidance, since the direction of the outlook signals where the cycle is heading. Commentary on demand for AI compute and memory testing reveals the strength of the boom. The performance of the robotics business indicates progress in diversification. Gross margins show pricing power. Exposure to China is worth monitoring. Finally, watch the balance between strong AI-driven demand and the natural cyclicality of testing, because that interplay determines Teradyne's path as the cycle evolves.






Please wait processing your request...